Table 1.
AMPLICON | SSCP ANALYSIS | HRMA/SEQUENCING1 | N. OF CASES |
---|---|---|---|
EXON 1 | WT | WT | 26 |
EXON 2 | WT | WT | 23 |
WT | c.[64G > A]+[=] | 1 | |
c.[64G > A]+[64G > A] | c.[64G > A]+[64G > A] | 2 | |
EXON 3 | WT | WT | 26 |
EXON 4 | WT | WT | 26 |
EXON 5 | WT | WT | 26 |
EXON 6 | WT | WT | 18 |
c.[504+35G > A]+[=] | c.[504+35G > A]+[=] | 7 | |
c.[481G > C]+[=] | c.[481G > C]+[=] | 1 | |
EXON 7 | WT | WT | 19 |
c.[536A > G]+[536A > G] | c.[536A > G]+[536A > G] | 2 | |
c.[536A > G]+[=] | c.[536A > G]+[=] | 5 | |
EXON 8 | WT | WT | 26 |
EXON 9 | WT | WT | 26 |
EXON 10 | WT | WT | 26 |
EXON 11 | WT | WT | 26 |
EXON 12 | WT | WT | 16 |
c.[1014G > C]+[=] | c.[1014G > C]+[=] | 6 | |
WT | c.[1014G > C]+[1014G > C] | 1 | |
c.[1147delC]+[=] | c.[1147delC]+[=] | 1 | |
c.[1023_1024insGA]2+[=] | c.[1023_1024insGA]2+[=] | 1 | |
c.[1163T > C]+[=] | c.[1163T > C]+[=] | 1 | |
EXON 13 | WT | WT | 19 |
c.[1187G > A]+[1187G > A] | c.[1187G > A]+[1187G > A] | 1 | |
c.[1187G > A]+[=] | c.[1187G > A]+[=] | 4 | |
c.[1227_1228dupGG]+[1227_1228dupGG] | c.[1227_1228dupGG]+[1227_1228dupGG] | 1 | |
c.[1187-27C > T(+)1258C > A]3 | c.[1187-27C > T(+)1258C > A]3 | 1 | |
EXON 14 | WT | WT | 24 |
c.[1437_1439delGGA]+[=] | c.[1437_1439delGGA]+[=] | 1 | |
c.[1437_1439delGGA]+[1437_1439delGGA] | c.[1437_1439delGGA]+[1437_1439delGGA] | 1 | |
EXON 15 | WT | WT | 26 |
EXON 16 | WT | WT | 26 |
1In bold genetic variants identified by direct sequencing and HRMA, but not by SSCP.
2Novel variant identified in this study.
3These two variants were present in the same sample, but their phase is unknown.
WT = wild-type.